Asessment Of Serum Angiopoietin_2 Level In Patients With Psoriasis Vulgaris

Evaluation of Serum Levels of Adiponectin and Myonectin in Psoriasis Vulgaris Patients with and Without Metabolic Syndrome

Assessment of Serum Level of Claudin‐3 and Its Association with Disease Severity in Patients with Psoriasis Vulgaris

Assessment of Retinal Vasculature in Patients with Psoriasis

Serum Lipocalin-2 in Patients with Psoriasis Vulgaris in Relation to Itching and Psoriasis Severity

Serum Level of IL-33 in Vitiligo

Serum anti-tissue transglutaminase IgA antibodies in patients with psoriasis vulgaris and relation to its severity

Evaluation of Serum Human B-Defensins in Psoriasis Vulgaris Patients

Role of serum IL-26 in Pathogenesis of Psoriasis vulgaris

Serum Endocan Levels in Patients with Psoriasis Vulgaris as a Marker of Disease Severity